References
- AOABEYOOLU, I., 1991, DISSOL92 Program for Release Kinetics from Sustained Release Type dosage Forms, Version 3.2, Dept Pharm. Techn., Faculty of Pharmacy, Gazi University, O6330 Ankara, Turkey.
- ANONYMOUS, KELCO, Alginate Products for Scientific Water Control, Division of Merck & Co. Inc., Third ed. (London, UK).
- BHAGAT, H. R., MENDES, R. W., MATIllowITZ, E., and BHARGAVA, H. N., 1994, Kinetics and mechanism of drug release from calcium alginate membrane coated tablets. Drug Development and Industrial Pharmacy, 20, 387–394.
- GRAY, C. J., and DOWSETT, J., 1988, Retention of insulin in alginate gel beads. Biotechnology and Bioengineering, 31, 607–612.
- MCDOWELL, R. H., 1986, Properties of Alginates, Fifth ed. (London, UK: Kelco International).
- MICHAELS, A. S., 1965, Polyelectrolyte complexes Industrial and Engineering Chemistry, 57, 32–40.
- MUMPER, R. J., HoFFMAN, A. S., PUOLAKKINEN, P. A., BoucHARD, L. S., and GOIMBOTZ, W. R., 1994, Calcium-alginate beads for the oral delivery of transforming growth factor-$l (TGF-13 1): stabilization of TGF-J3 1 by the addition of polyacrylic acid within acid-treated beads. Journal of Controlled Release, 30, 241–251.
- MURATA, y. NAKADA, K., MIYAMOTO, E., KAWASHIMA, S., and SEO, S. H., 1993, Influence of erosion of calcium-induced alginate gel matrix on the release of brilliant blue. Journal of Controlled Release, 23, 21–26.
- ORAcEsKA, B., NIXON, J. R., WILLIAMS, S. C. R., and SOLOMON, M. C., 1992, A non-invasive method for following the kinetics of ion binding and structural changes in alginates, coupled with the dissolution from alginate matrices. Proceedings of the 10th Pharmaceutical Technology Conference, 1, 514–520.
- OSTBERG, T., and GRAFFNER, C., 1994, Calcium alginate matrices for oral multiple unit administration III. influence of calcium concentration, amount of drug added and alginate characteristics on drug release. International Journal of Pharmaceutics, 111, 272–282.
- OSTBERG, T., LuND, E. M., and GRAFFNER, C., 1994, Calcium alginate matrices for oral multiple unit administration: IV. release characteristics in different media International Journal of Pharmaceutics, 112, 241–248.
- POLK, A., AMSDEN, B., DE YAo, K., PENG, T., and GOOSENA, A., 1994, Controlled release of albumin from chitosan-alginate microcapsules. Journal of Pharmaceutical Sciences, 83, 178–185.
- RITGER, P. L., and PEppAs, N. A., 1987, A simple equation for description of solute release II. Fickian and anomalous release from swellable devices Journal of Controlled Release, 5, 37–42.
- SHERAISHI, S., ARAIRRA, M., IMAI, T., and oT
- AGIRI, M., 1990, Enhancement of dissolution rates of several drugs by low-molecular chitosan and alginate. Chemical Pharmaceutical Bulletin, 38, 185–187.
- SICJAK-13RAEK, G., 1992, Alginates: biosyntheses and some structure-function relationships relevant to biomedical and bioechnological applications. Biochemistry of Plant Polysaccharides, 20, 27–33.
- SUGAWARA, S., IMAI, T., and OTAGIRI, M., 1994, The controlled release of prednisolone using alginate gel. Pharmaceutical Research, 11, 272–277.
- TAKAHASHI, T., TAKAYAMA, K., MACHIDA, y., and NAGAI, T., 1990, Characterisics of polyion complexes of chitosan with sodium alginate and sodium polyacrylate. International Journal of Pharmaceutics, 61, 35–41.
- WAGNER, J. G., 1987, Single intravenous dose and steady-state oral dose pharmacokinetics of nicardipine in healthy subjects Biopharmaceutics and Drug Disposition, 8, 133–148.
- WAN, L. S. C., Lim, L. Y., and SOH, B. L., 1994, Relationship between swelling and drug release in a hydrophilic matrix. Drug Development and Industrial Pharmacy, 19, 1201–1210.